Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 142

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 2
Chunk 142
---
 in millions)20252024$ change20252024 $ changeDiluted earnings per share$0.98$1.02$(0.05)$3.26$2.77$0.49Add: Non-operating benefit (income) costs    (0.16)(0.22)(0.49)(0.67)Add: Restructuring costs(1)    0.07 0.05 0.16 0.20 Add: Acquisition and disposition-related charges (benefits)(2)    0.02 (0.01)0.05 (0.02)Add: Spin-Off and separation costs(3)    0.01 0.12 0.09 0.40 Add: (Gain) loss on business and asset dispositions(4)    — 0.00 (0.01)— Add: Amortization of acquisition-related intangible assets    0.09 0.08 0.25 0.22 Add: Investment revaluation (gain) loss(5)    (0.01)0.00 (0.21)0.06 Add: Tax effect of reconciling items(6)(0.00)(0.01)(0.01)(0.06)Add: Spin-Off and other tax adjustments(7)    0.09 0.10 0.05 0.13 Adjusted earnings per share*$1.07$1.14$(0.06)$3.15$3.04$0.11Diluted weighted-average shares outstanding457459458459

(1)Consists of severance, facility closures, and other charges associated with restructuring programs.(2)Consists of legal, consulting, and other transaction and integration fees, and adjustments to contingent consideration, as well as other purchase accounting related charges and other costs directly related to the transactions.(3)Costs incurred in the Spin-Off and separation from GE, including system implementations, audit and advisory fees, legal entity separation, Founders Grant equity awards, separation agreements with GE, and other one-time costs. An adjustment is included to eliminate the associated impact on Net (income) loss attributable to noncontrolling interests for applicable costs that impact earnings attributable to noncontrolling interests.(4)Consists of gains and losses resulting from the sale of assets and investments.(5)Primarily relates to valuation adjustments